Oracle’s Lobbying and Recent Trading Activity Revealed
In a special lobbying report, $15,000 has been attributed to LIVINGSTON GROUP (ON BEHALF OF ORACLE) for Q4 of 2024, according to a new filing under the Lobbying Disclosure Act.
This lobbying focused on issues categorized as:
“None”
For more insights on corporate lobbying, visit Quiver Quantitative.
Congressional Stock Activity in ORCL
In the past six months, members of Congress have engaged in $ORCL stock trades two times, consisting of one purchase and one sale.
Below is a summary of congressional trading related to $ORCL stock within this timeframe:
To keep up with congressional stock trades, check Quiver Quantitative’s dedicated trading dashboard.
Recent Insider Trading at ORCL
Insiders at Oracle have conducted ten stock transactions on the open market over the last six months, with no purchases and all ten being sales.
Here’s a summary of the insider trading activity for $ORCL over the last six months:
For updates on insider transactions, refer to Quiver Quantitative’s dashboard for insider trading.
Hedge Fund Moves Involving ORCL
A total of 1,397 institutional investors have added shares of $ORCL stock to their portfolios, while 1,181 have reduced their holdings in the latest quarter.
Highlights from these adjustments include:
- POLEN CAPITAL MANAGEMENT LLC added 8,767,967 shares (+inf%) in Q3 2024
- FRANKLIN RESOURCES INC increased their holdings by 5,052,479 shares (+31.4%) in Q3 2024
- MASSACHUSETTS FINANCIAL SERVICES CO /MA/ cut 2,963,979 shares (-36.4%) from their portfolio in Q3 2024
- PRICE T ROWE ASSOCIATES INC /MD/ added 2,773,479 shares (+54.7%) in Q3 2024
- FMR LLC decreased their position by 2,192,682 shares (-5.5%) in Q3 2024
- WINSLOW CAPITAL MANAGEMENT, LLC added 2,084,245 shares (+inf%) in Q3 2024
- INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC increased their position by 2,052,275 shares (+16023.4%) in Q3 2024
To explore hedge fund stock portfolios further, visit Quiver Quantitative’s institutional holdings dashboard.
This article does not constitute financial advice. Please refer to Quiver Quantitative’s disclosures for more information.
This article was initially published on Quiver News; read the full story.
The views and opinions expressed herein are solely those of the author and do not necessarily reflect the views of Nasdaq, Inc.
